SLC47A1 and cancer: We not only demonstrate a complete lack of similarity of the compound’s antitumor profile with that of the classical platinum drugs, but also discovered a membrane transporter, human multidrug and toxin extrusion protein, hMATE1 (SLC47A1), as the single most predictive marker of chemosensitivity to platinum–acridines and demonstrate its potential utility as a target for personalized cancer treatment.